141496 <common-name>Barixibat</common-name> <description>Barixibat belongs to the linear 1,3-diarylpropanoids, a class of phenylpropanoids and polyketides within the organic compounds. It has the chemical formula C42H55N5O8. With an average molecular weight of 757.93 g/mol, Barixibat is a heavy molecule.</description> <cas>263562-28-3</cas> <pubchem-id>10234172</pubchem-id> <chemical-formula>C42H55N5O8</chemical-formula> <weight>757.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-15T17:53:24Z</created-at> <updated-at type="dateTime">2026-08-22T14:23:28Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB21209</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)NCCCCCCCCCCC(=O)NC1=C(C=CC=C1)[C@@H](NC1=NC=CC=C1)[C@@H]([C@H](O)C1=CC=CC=C1)C1=NC=CC=C1</moldb-smiles> <moldb-formula>C42H55N5O8</moldb-formula> <moldb-inchi>InChI=1S/C42H55N5O8/c48-28-33(49)39(52)40(53)41(54)42(55)45-27-15-6-4-2-1-3-5-10-24-35(50)46-31-21-12-11-20-30(31)37(47-34-23-14-17-26-44-34)36(32-22-13-16-25-43-32)38(51)29-18-8-7-9-19-29/h7-9,11-14,16-23,25-26,33,36-41,48-49,51-54H,1-6,10,15,24,27-28H2,(H,44,47)(H,45,55)(H,46,50)/t33-,36+,37-,38-,39-,40+,41-/m1/s1</moldb-inchi> <moldb-inchikey>LNLNLJFTSXTELN-TVKRVUGASA-N</moldb-inchikey> <moldb-average-mass type="decimal">757.929</moldb-average-mass> <moldb-mono-mass type="decimal">757.405063751</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM137389</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[2-[(1S,2R,3S)-3-hydroxy-3-phenyl-2-pyridin-2-yl-1-(pyridin-2-ylamino)propyl]phenyl]-11-[[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyl]amino]undecanamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Phenylpropanoids and polyketides</superklass> <klass>Linear 1,3-diarylpropanoids</klass> <subklass nil="true"/> <paper-count type="integer">1</paper-count> <sync-id>CED0067078</sync-id> <structure-inchikey>LNLNLJFTSXTELN-TVKRVUGASA-N</structure-inchikey> <structure-fingerprint>4000000040400000000080000000000000000000000000000400000a1004000000000000000000100000000000000020041008000000000080000000200004000000000000000104040080000000000000204010000020000000000000000020000010000100000500040000000002800000000000002000000000004020000000000000000000008010000000000100900002000001000000800000000010000000000000000000000004000a0000401000000000080000000100000000000000000008000400000000000800000000000000108000020000000220000000000000008000000000002048000008010400000008080000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAA3AAAAOgAAAIABCABgAAAAAQEGAGAAAAAC AgYgNAAAAAEBBAgAYAAAAAEBBiA0AAAAAQEECABgAAAAAQEGIDQAAAACAQQI AGAAAAABAQYgNAAAAAEBBAgAYAAAAAEBBgAoAAAAAwQIACgAAAADAgcAaAAA AAMCAQYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIG AGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgAoAAAA AwQIACgAAAADAgcAaAAAAAMCAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGIDQAAAABAQQHAGgAAAADAgEG QCgAAAADBAdAKAAAAAMDBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBo AAAAAwMBBiA0AAAAAQEEBiA0AAAAAgEECABgAAAAAQEGQCgAAAADBAZAaAAA AAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAA AAMEB0AoAAAAAwMGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAAD AwELAAEAAQIAAgMAAgQABAUABAYABgcABggACAkACAoACgsoAgoMIAwNAA0O AA4PAA8QABARABESABITABMUABQVABUWABYXABcYKAIXGSAZGiAaG2gMGxxo DBwdaAwdHmgMHh9oDBsgACAhACEiICIjaAwjJGgMJCVoDCUmaAwmJ2gMICgA KCkAKSoAKSsAKyxoDCwtaAwtLmgMLi9oDC8waAwoMQAxMmgMMjNoDDM0aAw0 NWgMNTZoDB8aaAwnImgMMCtoDDYxaAxCBAAAAAYaHx4dHBsGIyQlJiciBiwt Li8wKwYyMzQ1NjEXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:52:14Z</structure-indexed-at> </compound>